Myostatin (GDF-8) as a key factor linking muscle mass and bone structure.

Myostatin (GDF-8) is a member of the transforming growth factor-beta (TGF-beta) superfamily that is highly expressed in skeletal muscle, and myostatin loss-of-function leads to doubling of skeletal muscle mass. Myostatin-deficient mice have been used as a model for studying muscle-bone interactions, and here we review the skeletal phenotype associated with altered myostatin signaling. It is now known that myostatin is a key regulator of mesenchymal stem cell proliferation and differentiation, and mice lacking the myostatin gene show decreased body fat and a generalized increase in bone density and strength. The increase in bone density is observed in most anatomical regions, including the limbs, spine, and jaw, and myostatin inhibitors have been observed to significantly increase bone formation. Myostatin is also expressed in the early phases of fracture healing, and myostatin deficiency leads to increased fracture callus size and strength. Together, these data suggest that myostatin has direct effects on the proliferation and differentiation of osteoprogenitor cells, and that myostatin antagonists and inhibitors are likely to enhance both muscle mass and bone strength.

[1]  L. Liang,et al.  Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. , 2010, The Journal of trauma.

[2]  Cain,et al.  Effects of Recombinant Myostatin Propeptide on Fracture Repair in a Fibula Osteotomy Model , 2009 .

[3]  K. Wenger,et al.  Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. , 2009, Bone.

[4]  B. Picard,et al.  Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets , 2009, BMC Genomics.

[5]  Se-Jin Lee,et al.  Redundancy of myostatin and growth/differentiation factor 11 function , 2009, BMC Developmental Biology.

[6]  Jack C. Yu,et al.  Enlargement of the temporalis muscle and alterations in the lateral cranial vault. , 2008, Integrative and comparative biology.

[7]  M. Stack,et al.  Using "Mighty Mouse" to understand masticatory plasticity: myostatin-deficient mice and musculoskeletal function. , 2008, Integrative and comparative biology.

[8]  K. Wagner,et al.  Myostatin Directly Regulates Skeletal Muscle Fibrosis* , 2008, Journal of Biological Chemistry.

[9]  S. Bhasin,et al.  The Effects of Myostatin on Adipogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells Are Mediated through Cross-communication between Smad3 and Wnt/β-Catenin Signaling Pathways* , 2008, Journal of Biological Chemistry.

[10]  H. Seeherman,et al.  Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass , 2008 .

[11]  Konstantin I Bakhurin,et al.  Tendons of myostatin-deficient mice are small, brittle, and hypocellular , 2008, Proceedings of the National Academy of Sciences.

[12]  C. Byron,et al.  Craniofacial Morphology in Myostatin-deficient Mice , 2007, Journal of dental research.

[13]  F. Ambrosio,et al.  Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. , 2007, The Journal of biological chemistry.

[14]  G. Cabello,et al.  The myostatin gene: physiology and pharmacological relevance. , 2007, Current opinion in pharmacology.

[15]  K. Wenger,et al.  Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. , 2007, Bone.

[16]  Emily B. Klopp,et al.  Plasticity of mandibular biomineralization in myostatin‐deficient mice , 2007, Journal of morphology.

[17]  M. Stack,et al.  Pushing the limit: masticatory stress and adaptive plasticity in mammalian craniomandibular joints , 2007, Journal of Experimental Biology.

[18]  R. Wall,et al.  In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiometry. , 2007, Growth, development, and aging : GDA.

[19]  H. Zhang,et al.  Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families , 2007, Osteoporosis International.

[20]  S. Choe,et al.  Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Hamrick,et al.  Resistance to body fat gain in ‘double-muscled’ mice fed a high-fat diet , 2006, International Journal of Obesity.

[22]  James M Reecy,et al.  Transcriptional profiling of myostatin‐knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Hamrick,et al.  Increased Muscle Mass With Myostatin Deficiency Improves Gains in Bone Strength With Exercise , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  Elisabeth K. Nicholson,et al.  Biomineralization and adaptive plasticity of the temporomandibular joint in myostatin knockout mice. , 2006, Archives of oral biology.

[25]  S. Bhasin,et al.  Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. , 2005, Endocrinology.

[26]  Se-Jin Lee.  Regulation of muscle mass by myostatin. , 2004, Annual review of cell and developmental biology.

[27]  M. Lafage-Proust,et al.  Increase of Both Angiogenesis and Bone Mass in Response to Exercise Depends on VEGF , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  Jack C. Yu,et al.  Effects of increased muscle mass on mouse sagittal suture morphology and mechanics. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[29]  T. Braun,et al.  Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[30]  K. Tsuchida.  Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. , 2004, Current drug targets. Immune, endocrine and metabolic disorders.

[31]  C. Byron,et al.  Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF‐8 (myostatin) , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[32]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[33]  T. Fielder,et al.  Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. , 2003, American journal of physiology. Endocrinology and metabolism.

[34]  M. Hamrick.  Increased bone mineral density in the femora of GDF8 knockout mice. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[35]  T. Zimmers,et al.  Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.

[36]  Thomas A Einhorn,et al.  Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  Se-Jin Lee,et al.  Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.

[38]  C. Lovejoy,et al.  Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice , 2002, Calcified Tissue International.

[39]  Eckhard Schoenau,et al.  The Developing Bone: Slave or Master of Its Cells and Molecules? , 2001, Pediatric Research.

[40]  S. Bhasin,et al.  Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. , 2001, American journal of physiology. Endocrinology and metabolism.

[41]  V. Rosen,et al.  Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. , 2001, Developmental biology.

[42]  C. Lovejoy,et al.  Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice. , 2000, Bone.

[43]  H. Frost.  Muscle, bone, and the Utah paradigm: a 1999 overview. , 2000, Medicine and science in sports and exercise.

[44]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[45]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[46]  A. Joyner,et al.  Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.

[47]  P. Dijke,et al.  Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[48]  H. Frost,et al.  On Our Age‐Related Bone Loss: Insights from a New Paradigm , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  S. P. Oh,et al.  The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. , 1997, Genes & development.

[50]  M. Bouvier.  Effects of Age on the Ability of the Rat Temporomandibular Joint to Respond to Changing Functional Demands , 1988, Journal of dental research.

[51]  M. Bouvier,et al.  Effects of mechanical loads on surface morphology of the condylar cartilage of the mandible in rats. , 1987, Acta anatomica.

[52]  K. Borer.  Characteristics of growth-inducing exercise , 1980, Physiology & Behavior.